6-K ·Filed May 12, 2026

RDY

DR REDDYS LABORATORIES LTD
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago SEC0001575872-26-000303
Notable filing: 6-K
Actionable Insight • Neutral

The filing lacks extractable financial data. Monitor for a subsequent press release or analyst call for actual Q4 results and forward guidance.

DirectionNeutral
Confidencelow
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
RDY ▼ -5.93% at T+60d
NEUTRAL call ✗ call lost -5.93% · α vs SPY -10.37% · entry $12.99 → $12.22
Entry anchored
May 12, 03:59 PM ET
via exchange tick
T+1d
0.00%
call 0.00% · α +0.00%
$12.99
settled 5mo ago
T+5d
+3.54%
call +3.54% · α +4.70%
$13.45
settled 5mo ago
T+20d
+2.85%
call +2.85% · α +3.46%
$13.36
settled 4mo ago
T+60d
-5.93%
call -5.93% · α -10.37%
$12.22
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Dr. Reddy's Laboratories filed its Q4 FY26 audited financial results presentation via a 6-K on May 12, 2026. The filing is a routine earnings disclosure with no specific financial figures or guidance provided in the document text, making the material impact unclear.

Key Facts

  • Filed Q4 FY26 audited financial results presentation under Regulation 30 of SEBI Listing Regulations
  • Filing date: May 12, 2026
  • No specific financial figures (revenue, EPS, margins) or guidance were disclosed in the filing text
  • Document content consists of a cover letter and graphic images of the presentation, not extractable text

Financial Impact

No financial figures available in the filing text

Risk Factors

  • No quantitative data to assess performance
  • Potential for negative surprise if results are weak

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
50% bullish (44 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001575872-26-000303
Document: 0001575872-26-000303-index.html0001575872-26-000303
Document: 0001575872-26-000303.txt0001575872-26-000303
51 reports for RDY
Performance horizon
67% Hit rate 6 of 9 directional calls best @ T+20▲ +23.28%Jun 26, 2026
Filters
Rows
Reports for RDY — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
6-K
NEUTRAL ★ 3/10
$11.91 $11.55▼ −3.02%▼ −2.56%$12.25 (+2.85%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 5/10
$11.71 $11.90▲ +1.62%▲ +0.77%$12.25 (+4.61%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 2/10
$11.71 $11.90▲ +1.62%▲ +0.77%$12.25 (+4.61%)
Aug 26, 2026
5w ago
6-K
NEUTRAL ★ 2/10
$12.22 $12.16▼ −0.49%▼ −1.15%$12.25 (+0.25%)
Aug 17, 2026
6w ago
6-K
MIXED ★ 5/10
$12.11 $12.15▲ +0.33%▲ +1.01%$12.25 (+1.16%)
Aug 13, 2026
7w ago
6-K
NEUTRAL ★ 3/10
$12.42 $12.27▼ −1.21%▼ −1.01%$12.25 (−1.37%)
Aug 10, 2026
7w ago
6-K
NEUTRAL ★ 2/10
$12.15 $12.45▲ +2.47%▲ +2.79%$12.25 (+0.82%)
Aug 3, 2026
8w ago
6-K
BULLISH ★ 6/10
$12.07 $12.10▲ +0.25%▼ −1.55%$12.25 (+1.49%)
Jul 29, 2026
9w ago
6-K
NEUTRAL ★ 4/10
$11.76 $11.83▲ +0.60%▼ −1.08%$12.25 (+4.17%)
Jul 23, 2026
10w ago
6-K
NEUTRAL ★ 2/10
$11.80 $11.79▼ −0.08%▼ −0.19%$12.25 (+3.81%)
Showing 10 of 51

US Market Status

Market Closed — Opens Mon (65h 26m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access